Biotechnology News

September 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that it has been granted a six month extension until March 18, 2013 of the grace...

September 20, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics hosted an international conference on galectins and disease September 17-19. The proceedings will be published in early 2013.

September 20, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech President, Mike Klein to present at Michigan HIMSS Chapter HITECH Fall Conference in Detroit, Michigan.

September 20, 2012

PARIS--(BUSINESS WIRE)--The international jury under the presidency of Professor Iain Robinson (National Institute for Medical Research, London, UK) awarded on September 12th, 2012, the 11th Endocrine Regulation Prize of the Fondation Ipsen (20....

September 20, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced that Chief Executive Officer Michael L. Krall is schedule to present at the Aegis Capital...

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND appoints Daniel S. Lynch as Chairman of the company’s board of directors.

September 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Updated Infosario brings The Data Driven Difference™– to harnessing the power of data from diverse sources in near real-time to help customers make the best possible decisions

September 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A new study finds that, on average, drug companies dedicate more money to market research prior to launch than any other pharmaceutical marketing activity, according to Cutting Edge Information.

September 20, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today the passing of one of its Board Members, Gregory H. Barnhill. Mr. Barnhill has served on Osiris’ Board of Directors since the company went public in August...

September 20, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics announces agenda for its Investor Day event on Oct.9. Safeguard is going green to minimize impact on the environment... RSVP by Oct.5 at...

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the fourth annual Gaucher Leadership Forum (GLF) will take place on September 21 and 22 in Munich, Germany.

September 20, 2012

MALVERN, Pa.--(BUSINESS WIRE)--DSG, Inc., a leader in clinical data management and electronic data capture for clinical trials invites the media to meet with Suzanne Lamerand, vice president of data management for DSG at the upcoming annual...

September 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles announced Dr. Brian J. Kelly as the company’s new president of Payer & Provider Solutions.

September 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has entered into a $35 million common stock purchase agreement with Lincoln Park...

September 20, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David...

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced that it has entered into a strategic partnership with The Leukemia & Lymphoma Society® (...

September 20, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--USPTO issued five U.S. patents to BIND covering BIND-014,its lead Accurin product for solid cancer tumors, and its Medicinal NanoengineeringTM platform.

September 20, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore announces their continued support of Everybody Wins! Metro Boston- the local chapter of a national literacy and mentoring non-profit organization.

September 20, 2012

TORONTO--(BUSINESS WIRE)--Several of these markets, including the Nordic countries and Switzerland, have suffered less from the European debt crisis, and will see increased adoption of premium-priced products.

September 20, 2012

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) and Kadmon Corporation, LLC (Kadmon) announced today that they have entered into a strategic licensing agreement in which Kadmon has been granted an exclusive worldwide...

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine Announces $42.5 Million Series B Financing

September 20, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--UK scientists report successful testing of Aradigm’s inhaled liposomal ciprofloxacin in Q Fever, a highly infectious and life threatening bioterrorism infection.

September 20, 2012

SAN FRANCISCO & BOSTON--(BUSINESS WIRE)--Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease

September 20, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Acton Pharmaceuticals received FDA approval today for a new asthma medication, AEROSPAN. This is the company’s first FDA product approval and they anticipate launching the product in early 2013.

September 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that new clinical data on its lead product candidate tivozanib, partnered with Astellas Pharma Inc. (TSE: 4503), as well as its HGF inhibitory antibody ficlatuzumab...

September 20, 2012

BISHOPS STORTFORD, England--(BUSINESS WIRE)--Dotmatics Limited, a leading provider of scientific informatics solutions announces that the Institute of Cancer Research UK has chosen Vortex to assist with the discovery of new cancer drugs.

September 20, 2012

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--ASCC Receives Samples of Revolutionary Patented Biomolecule Skin Cream

September 20, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For NON-US media only Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib*, the first irreversible...

September 20, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (OMX: MVIR), announced today that simeprevir (TMC435) and TMC647055, a non-nucleoside inhibitor (NNI) will enter a phase IIa interferon free combination trial. Simeprevir is a once...

September 19, 2012

WASHINGTON & CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The fifth annual BioPharm America™ conference kicked off in Boston, MA, today with the announcement of TransCelerate BioPharma, a new non-profit organization focused on accelerating...

September 19, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics files its quarterly financial results and provides an update on its core business.

September 19, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall announced it will be opening a state-of the-art Life Sciences Center of Excellence in Westborough, Massachusetts for life sciences customers in the northeast region of the U.S.

September 19, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that detailed results from its two pivotal clinical trials evaluating oral BG-12 (dimethyl fumarate) for the treatment of multiple sclerosis (MS) were published in the...

September 19, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (the “Company”) today announced that it has priced an underwritten public offering of $75.0 million in aggregate principal amount of its 7.00% senior...

September 19, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced the pricing of new term loans to be used in the refinancing of its existing senior secured bank debt. Syndication has completed for the new senior secured bank debt, comprising...

September 19, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced its support of the first national Myelofibrosis Awareness Day, which will be held on Sept. 20, 2012. The inaugural recognition day is being led by the MPN...

September 19, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) previously announced that it will host its 2012 Investor Conference on Tuesday, October 9, 2012 at the Ritz-Carlton Hotel in Chicago, IL, from 8:00 a.m. until approximately 3...

September 19, 2012

BOSTON & WASHINGTON & CARLSBAD, Calif.--(BUSINESS WIRE)--This year’s announcement of the best and brightest emerging biotech companies took place at BioPharm America™ in Boston today. The Fierce 15 is a much anticipated who’s who list of...

September 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seaside Therapeutics published two papers in Science Translational Medicine, supporting disease-modifying potential for drug, STX209 (arbaclofen), for the treatment of fragile X syndrome (FXS)

September 19, 2012

SEATTLE--(BUSINESS WIRE)--Scientists at the Allen Institute for Brain Science reported in the latest issue of the journal Nature that human brains share a consistent genetic blueprint and possess enormous biochemical complexity. The findings stem...

September 19, 2012

COLUMBUS, Ohio--(BUSINESS WIRE)--Today throughout Ohio, at least 1,280 bioscience-related organizations are either manufacturing products, providing essential services, or researching the next breakthrough. Ranging from the large and well known—...

September 19, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

September 19, 2012

MOUNT LAUREL, N.J.--(BUSINESS WIRE)--CRI Lifetree has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as Chief Operating Officer and Jose Marcos as East Coast Director of Clinical Operations.

September 19, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, has announced a new syndicated report series entitled LaunchTrends: Aubagio. Aubagio (...

September 19, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--AvidBiotics Corp. and DuPont Nutrition & Health (NYSE: DD) today announced a collaboration aimed at commercializing AvidBiotics’ Purocin™ antibacterial proteins to significantly improve food...

September 19, 2012

BONN, Germany--(BUSINESS WIRE)--Cardionovum: clinical trials confirm “excellent device performance with high procedural success and absence of clinical events out to six months follow-up”